Matthew O’Connor — Cyclarity and oxidized cholesterol
LinkedIn caption
🔬 A different approach to cardiometabolic and age-related disease was on the ARDD 2026 programme with Matthew O’Connor of Cyclarity.
His scheduled session, “Removing Oxidized Cholesterol: Clinical Trials for a New Approach to Cardiometabolic and Age-Related Disease,” brought oxidized cholesterol into the drug discovery conversation.
🙏 Thank you, Matthew and the Cyclarity team, for sharing this perspective with the ARDD community.
#ARDD2026 #DrugDiscovery #CardiometabolicHealth
X caption
🔬 Oxidized cholesterol in the drug discovery conversation at #ARDD2026. Matthew O’Connor’s Cyclarity session explored a new approach to cardiometabolic and age-related disease.
Thank you, Matthew and the team.
#DrugDiscovery
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
